These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11292806)

  • 21. New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region.
    Gola S; Martin R; Walther A; Dünkler A; Wendland J
    Yeast; 2003 Dec; 20(16):1339-47. PubMed ID: 14663826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker.
    Gácser A; Salomon S; Schäfer W
    FEMS Microbiol Lett; 2005 Apr; 245(1):117-21. PubMed ID: 15796988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of Candida albicans Tet-on tagging vectors with a Ura-blaster cassette.
    Lai WC; Tseng TL; Jian T; Lee TL; Cheng CW; Shieh JC
    Yeast; 2011 Mar; 28(3):253-63. PubMed ID: 21360736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
    Wirsching S; Michel S; Morschhäuser J
    Mol Microbiol; 2000 May; 36(4):856-65. PubMed ID: 10844673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods].
    Arikan S; Darka O; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2003 Jan; 37(1):49-57. PubMed ID: 12838678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment.
    Borecká-Melkusová S; Bujdáková H
    Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRZ1, a target of the calcineurin pathway in Candida albicans.
    Karababa M; Valentino E; Pardini G; Coste AT; Bille J; Sanglard D
    Mol Microbiol; 2006 Mar; 59(5):1429-51. PubMed ID: 16468987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-step cloning-free PCR-based method for the deletion of genes in the opportunistic pathogenic yeast Candida lusitaniae.
    El-Kirat-Chatel S; Dementhon K; Noël T
    Yeast; 2011 Apr; 28(4):321-30. PubMed ID: 21456057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker.
    François F; Chapeland-Leclerc F; Villard J; Noël T
    Yeast; 2004 Jan; 21(2):95-106. PubMed ID: 14755635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
    BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator.
    Brôco N; Tenreiro S; Viegas CA; Sá-Correia I
    Yeast; 1999 Nov; 15(15):1595-608. PubMed ID: 10572257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene deletion in Candida albicans wild-type strains using the SAT1-flipping strategy.
    Sasse C; Morschhäuser J
    Methods Mol Biol; 2012; 845():3-17. PubMed ID: 22328364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of antifungal drug resistance in Candida dubliniensis.
    Coleman DC; Moran GP; McManus BA; Sullivan DJ
    Future Microbiol; 2010 Jun; 5(6):935-49. PubMed ID: 20521937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.
    Wirsching S; Michel S; Köhler G; Morschhäuser J
    J Bacteriol; 2000 Jan; 182(2):400-4. PubMed ID: 10629186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of FLAG tagging vectors for Candida albicans.
    Umeyama T; Nagai Y; Niimi M; Uehara Y
    Yeast; 2002 May; 19(7):611-8. PubMed ID: 11967831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted gene deletion in Candida albicans wild-type strains by MPAR flipping.
    Morschhäuser J; Staib P; Köhler G
    Methods Mol Med; 2005; 118():35-44. PubMed ID: 15888933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.